KR100966627B1 - L-α-글리세로포스포릴 콜린의 제조방법 - Google Patents
L-α-글리세로포스포릴 콜린의 제조방법 Download PDFInfo
- Publication number
- KR100966627B1 KR100966627B1 KR1020060053441A KR20060053441A KR100966627B1 KR 100966627 B1 KR100966627 B1 KR 100966627B1 KR 1020060053441 A KR1020060053441 A KR 1020060053441A KR 20060053441 A KR20060053441 A KR 20060053441A KR 100966627 B1 KR100966627 B1 KR 100966627B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- reaction
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 title abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 238000002425 crystallisation Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 15
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 239000003456 ion exchange resin Substances 0.000 claims description 11
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 11
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000007810 chemical reaction solvent Substances 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 150000002576 ketones Chemical class 0.000 claims description 6
- -1 chlorine ions Chemical class 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 claims description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004327 boric acid Substances 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 7
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 abstract description 11
- CTKINSOISVBQLD-GSVOUGTGSA-N (R)-Glycidol Chemical compound OC[C@@H]1CO1 CTKINSOISVBQLD-GSVOUGTGSA-N 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 235000019743 Choline chloride Nutrition 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- VTDOEFXTVHCAAM-UHFFFAOYSA-N 4-methylpent-3-ene-1,2,3-triol Chemical compound CC(C)=C(O)C(O)CO VTDOEFXTVHCAAM-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Chemical group 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- ICVPTJCCKTXCDT-UHFFFAOYSA-L calcium;2-(trimethylazaniumyl)ethyl phosphate;chloride Chemical compound [Cl-].[Ca+2].C[N+](C)(C)CCOP([O-])([O-])=O ICVPTJCCKTXCDT-UHFFFAOYSA-L 0.000 description 1
- JGULOZKZZMBGFX-UHFFFAOYSA-L calcium;2-(trimethylazaniumyl)ethyl phosphate;chloride;tetrahydrate Chemical compound O.O.O.O.[Cl-].[Ca+2].C[N+](C)(C)CCOP([O-])([O-])=O JGULOZKZZMBGFX-UHFFFAOYSA-L 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000012358 sourcing Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Abstract
Description
Claims (15)
- 제1항에 있어서, 화학식 3의 화합물의 양이 화학식 4의 화합물의 양을 기준으로 1 내지 4 당량인 방법.
- 제1항에 있어서, 반응 pH가 5 내지 10이고, 반응온도가 40 내지 120℃인 방법.
- 제1항에 있어서, 반응이 C1-C6-알코올, C1-C6-에테르, C1-C6-케톤 및 이들의 혼합물로 구성된 그룹에서 선택된 반응 용매 중에서 수행되는 방법.
- 제4항에 있어서, 반응 용매가 메탄올, 에탄올, 테트라하이드로퓨란 및 이들의 혼합물로 구성된 그룹에서 선택되는 방법.
- 제4항에 있어서, C1-C6-알코올, C1-C6-케톤 및 이들의 혼합물로 구성된 그룹에서 선택된 결정화 용매를 첨가함으로써 화학식 5의 화합물을 결정화시키는 단계를 추가로 포함하는 방법.
- 제6항에 있어서, 결정화 용매가 이소프로필알콜, 아세톤 또는 이들의 혼합물인 방법.
- 제6항에 있어서, 결정화가 0℃ 내지 25℃의 온도 범위 내에서 수행되는 방법.
- 제6항에 있어서, 반응 용매를 제거하여 농축물을 형성시키는 단계; 형성된 농축물을 물에 용해시킨 뒤, 할로겐화 C1-C4-알칸, C1-C4-알콕시카보닐C1-C4-알칸, C3-C8-알코올 및 이들의 혼합물로 구성된 그룹에서 선택된 유기 용매를 사용하여 수층으로부터 불순물을 제거하는 단계; 및 수층으로부터 물을 제거한 뒤, 형성된 농축물을 C1-C6-알코올, C1-C6-에테르, C1-C6-케톤 및 이들의 혼합물로 구성된 그룹에서 선택된 유기 용매에 용해시키는 단계를, 결정화 용매의 첨가 전에 추가로 포함하는 방법.
- 제10항에 있어서, 산이 황산, 붕산, 인산, 질산, 염산, 옥살산, 아세트산, 에틸렌디아민테트라아세트산 및 구연산으로 구성된 그룹으로부터 선택되는 방법.
- 제10항에 있어서, 반응 pH가 2 이하이고, 반응온도가 -10 내지 60℃인 방법.
- 제10항에 있어서, 반응이 물, C1-C6-알코올, C1-C6-케톤 및 이들의 혼합물로 구성된 그룹에서 선택된 용매 중에서 수행되는 방법.
- 제14항에 있어서, 이온교환수지가 IONAC NM-60(Sybron Chemicals Inc.), Lewatit SM-94(Sybron Chemicals Inc.), IONAC NM-73(Sybron Chemicals Inc.), Dowex MB-46(Dow Chemical), Dowex MR-3(Dow Chemical), Amberite IRN-150(Rohm & Haas), Amberite MB-20(Rohm & Haas), MB-400(Purolite), NRW-37(Purolite) 및 IONAC NM60 SG(Bayer)로 구성된 그룹에서 선택되는 방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060053441A KR100966627B1 (ko) | 2006-06-14 | 2006-06-14 | L-α-글리세로포스포릴 콜린의 제조방법 |
PCT/KR2007/002889 WO2007145476A1 (en) | 2006-06-14 | 2007-06-14 | A process for preparation of l-alpha-glycerophosphoryl choline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060053441A KR100966627B1 (ko) | 2006-06-14 | 2006-06-14 | L-α-글리세로포스포릴 콜린의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070119176A KR20070119176A (ko) | 2007-12-20 |
KR100966627B1 true KR100966627B1 (ko) | 2010-06-29 |
Family
ID=38831945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060053441A Active KR100966627B1 (ko) | 2006-06-14 | 2006-06-14 | L-α-글리세로포스포릴 콜린의 제조방법 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100966627B1 (ko) |
WO (1) | WO2007145476A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160116463A (ko) | 2015-03-30 | 2016-10-10 | 주식회사 한서켐 | L-α-글리세릴 포스포릴 콜린의 III형 결정 및 그 제조방법 |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100904727B1 (ko) * | 2007-10-17 | 2009-06-26 | 한양대학교 산학협력단 | 글리세릴 포스포릴콜린의 합성 방법 |
KR100951108B1 (ko) * | 2008-04-15 | 2010-04-07 | 엔자이텍 주식회사 | 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법 |
KR101019728B1 (ko) * | 2008-09-29 | 2011-03-07 | 엔자이텍 주식회사 | 라세믹 또는 광학적으로 활성이 있는 α―포스파티딜콜린 유도체의 제조방법 |
KR101023455B1 (ko) * | 2008-12-29 | 2011-03-25 | 엔자이텍 주식회사 | 라세믹 또는 광학적으로 활성이 있는 α―글리세로포스포릴콜린의 제조방법 |
DE102009052034A1 (de) * | 2009-11-05 | 2011-05-12 | Merck Patent Gmbh | Synthese von Phosphorestern |
KR101330814B1 (ko) * | 2009-12-10 | 2013-11-15 | 주식회사 한서켐 | 콜린 알포세레이트의 제조방법 |
CN102093410B (zh) * | 2011-01-11 | 2015-04-22 | 江南大学 | 一种用硅胶柱层析法分离纯化甘油磷酸胆碱的方法 |
CN103429603A (zh) | 2011-03-14 | 2013-12-04 | 株式会社韩西克慕 | 甘油磷酰胆碱的i型和ii型结晶及其制造方法 |
US8981141B1 (en) | 2011-03-14 | 2015-03-17 | Hanseochem Co., Ltd. | I-and II-type crystals of L-A-glyceryl phosphoryl choline, and method for preparing same |
KR101233138B1 (ko) * | 2012-11-06 | 2013-02-22 | 주식회사 한서켐 | L-α-글리세릴 포스포릴 콜린의 제조방법 |
CN103172659A (zh) * | 2013-03-29 | 2013-06-26 | 山东罗欣药业股份有限公司 | L-α-甘油磷酰胆碱晶型化合物 |
KR101616945B1 (ko) * | 2014-02-10 | 2016-04-29 | 엔자이텍 주식회사 | 라세믹 또는 광학적으로 활성이 있는 α―글리세로포스포릴 콜린의 제조방법 |
ES2695505T3 (es) * | 2014-06-10 | 2019-01-08 | Chemi Spa | Proceso para la purificación de L-alfa-glicerofosforilcolina |
KR20160037031A (ko) * | 2014-09-26 | 2016-04-05 | 엔자이텍 주식회사 | 라세믹 또는 광학적으로 활성이 있는 D 또는 L-α-글리세로포스포릴콜린 고체의 제조방법 |
CN104628766B (zh) * | 2015-01-16 | 2017-02-22 | 王志训 | 一种甘油磷酸胆碱的工业制造方法 |
CN108101937B (zh) * | 2017-11-13 | 2020-03-10 | 湖南华纳大药厂手性药物有限公司 | 一种制备L-α-甘油磷脂酰胆碱的方法 |
CN108191908B (zh) * | 2017-12-28 | 2020-04-21 | 上海科一生物医药有限公司 | 一种L-α-甘油磷酸胆碱的制备方法 |
CN109021010B (zh) * | 2018-06-25 | 2020-08-07 | 金久奇(抚顺)药业有限公司 | 一种L-α-甘磷酸胆碱的制备方法 |
CN109265477A (zh) * | 2018-11-13 | 2019-01-25 | 科利生物科技(徐州)有限公司 | L-ɑ-甘油磷酸胆碱的制备方法 |
KR102221211B1 (ko) | 2019-02-13 | 2021-03-03 | 한국바이오켐제약 주식회사 | 콜린알포세레이트의 제조방법 및 이를 포함하는 약학제제 |
KR20230023339A (ko) | 2021-08-10 | 2023-02-17 | 스마트바이오팜 주식회사 | 연속흐름공정을 이용하여 콜린알포세레이트를 제조하는 방법 |
KR102595126B1 (ko) | 2022-09-27 | 2023-10-30 | 하나제약 주식회사 | 콜린알포세레이트 에스테르 유도체의 제조방법과 그 용도 |
KR20240124730A (ko) | 2023-02-09 | 2024-08-19 | 스마트바이오팜 주식회사 | 연속흐름공정을 이용하여 콜린알포세레이트를 제조하는 방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005479A1 (en) * | 1993-08-17 | 1995-02-23 | The Regents Of The University Of California | Assay and substrate for arachidonoyl-specific phospholipase a¿2? |
WO1997044053A1 (en) * | 1996-05-20 | 1997-11-27 | Flarer S.A. | Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
JP2006111624A (ja) | 2004-10-13 | 2006-04-27 | Chemi Spa | リゾホスファチジルコリンの製造方法 |
JP4086305B2 (ja) | 2003-12-02 | 2008-05-14 | 株式会社資生堂 | ホスホリルコリン基含有化合物及び該化合物からなる表面改質剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH085904B2 (ja) * | 1986-05-02 | 1996-01-24 | オリエンタル酵母工業株式会社 | 新規ホスホリルコリン誘導体の製造法 |
US5137660A (en) * | 1991-03-15 | 1992-08-11 | The Procter & Gamble Company | Regioselective synthesis of 1,3-disubstituted glycerides |
DE10133202A1 (de) * | 2001-07-07 | 2003-01-16 | Beiersdorf Ag | Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
-
2006
- 2006-06-14 KR KR1020060053441A patent/KR100966627B1/ko active Active
-
2007
- 2007-06-14 WO PCT/KR2007/002889 patent/WO2007145476A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005479A1 (en) * | 1993-08-17 | 1995-02-23 | The Regents Of The University Of California | Assay and substrate for arachidonoyl-specific phospholipase a¿2? |
WO1997044053A1 (en) * | 1996-05-20 | 1997-11-27 | Flarer S.A. | Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
JP4086305B2 (ja) | 2003-12-02 | 2008-05-14 | 株式会社資生堂 | ホスホリルコリン基含有化合物及び該化合物からなる表面改質剤 |
JP2006111624A (ja) | 2004-10-13 | 2006-04-27 | Chemi Spa | リゾホスファチジルコリンの製造方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160116463A (ko) | 2015-03-30 | 2016-10-10 | 주식회사 한서켐 | L-α-글리세릴 포스포릴 콜린의 III형 결정 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20070119176A (ko) | 2007-12-20 |
WO2007145476A1 (en) | 2007-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100966627B1 (ko) | L-α-글리세로포스포릴 콜린의 제조방법 | |
EP3106465B1 (en) | Method for preparing racemic or optically active glycerophosphoryl choline | |
JP2011246429A (ja) | アダマンチル基を有する第4級アンモニウム塩の製造方法 | |
KR101653064B1 (ko) | 가도부트롤의 제조방법 | |
JPH08505382A (ja) | N−ホスホノメチルイミノジ酢酸の製造方法 | |
KR100951108B1 (ko) | 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법 | |
KR20180056162A (ko) | 이미노디아세트산의 제조방법 | |
KR101330814B1 (ko) | 콜린 알포세레이트의 제조방법 | |
DE69909165T2 (de) | Verfahren zur Herstellung von N-Glycyltyrosin | |
WO2014012988A1 (en) | Method for the synthesis of n-(phosphonomethyl)glycine | |
JPS5843939A (ja) | マンデル酸塩及びその製法 | |
KR101233138B1 (ko) | L-α-글리세릴 포스포릴 콜린의 제조방법 | |
KR20190088793A (ko) | 칼코부트롤의 제조방법 | |
JP2013508440A (ja) | ホスホノアルキルイミノ二酢酸の製造のための方法 | |
KR20220147435A (ko) | 카르밤산염 화합물의 제조방법 | |
CN103819505B (zh) | 一种提高双甘膦收率的方法 | |
CS239903B2 (en) | Processing of aminomethyl phosphoric acid derivatives | |
CN100364963C (zh) | 制备o-取代羟胺的方法 | |
JPH01228995A (ja) | N―ホスホノ―メチル―イミノージ酢酸及び酸塩化物の製造方法 | |
JP3901321B2 (ja) | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 | |
US2517856A (en) | Method of preparing diphenyl acetic acid | |
JP3896113B2 (ja) | N−ホスフォノメチルグリシンの製造方法 | |
CN101245037B (zh) | 一种氧甲基异脲醋酸盐的制备方法 | |
JPH07330787A (ja) | テトラ置換ホスホニウム有機酸塩の合成法 | |
JPH08134088A (ja) | N−ホスホノメチルグリシンの単離方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20060614 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20100202 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20060614 Comment text: Patent Application |
|
A302 | Request for accelerated examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20100203 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20060614 Patent event code: PA03021R01I Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20100322 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20100621 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20100622 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20130327 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20140306 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20150306 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20160329 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170403 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20170403 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20180404 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20190402 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20200507 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20210405 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20220329 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20230314 Start annual number: 14 End annual number: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20240327 Start annual number: 15 End annual number: 15 |